Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China · Delayed Price · Currency is CNY 36.17
-2.75 (-7.07%)
Jun 8, 2026, 3:04 PM CST
SHE:300347 Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, SHE:300347 stock has a consensus rating of "Buy" and an average price target of ¥63.81. The average 1-year stock price forecast is 76.42% higher than the current stock price, while the lowest is ¥41.00 (+13.35%) and the highest is ¥79.25 (+119.10%).
Price Target: ¥63.81 (+76.42%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHE:300347 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 10 | 9 | 10 | 10 | 10 |
| Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 18 | 16 | 17 | 17 | 17 |
Financial Forecast
Revenue This Year
7.73B
from 6.83B
Increased by 13.13%
Revenue Next Year
8.77B
from 7.73B
Increased by 13.48%
EPS This Year
1.44
from 0.42
Increased by 242.38%
EPS Next Year
1.51
from 1.44
Increased by 5.25%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 7.8B | ||
| Avg | 7.7B | ||
| Low | 7.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.8% | ||
| Avg | 13.1% | ||
| Low | 11.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.44 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 242.4% | ||
| Low | - |